DSC Investment

DSC Investment Research

Investment Thesis

DSC Investment is one of South Korea's leading venture capital firms, founded in 2012 by Yoon Geon-su (CEO), who previously led investments at Korea Technology Investment and LB Investment since the late 1990s. The firm invests in paradigm-leading innovative entrepreneurs across early-stage and growth-stage startups. While DSC is strongest at early-stage (Seed and Series A), it remains open to all stages for companies with strong teams and compelling opportunities.

DSC is especially known for pioneering investments in deep tech—including AI, semiconductors, biotech, and secondary batteries—well before these sectors became mainstream. The firm distinguishes itself as a talent scout for the Korean startup ecosystem, with a track record of identifying unicorns and pre-IPO winners years before public markets recognized their value.

Sector Focus

DSC invests across a broad range of sectors with particular depth in:

• Deep tech: AI semiconductors (FuriosaAI, SemiFive), data processing units (MangoBoost), physical AI for manufacturing (CarbonSix)
• Biotech and life sciences: oncology therapeutics (Pinetree Therapeutics, ABL Bio), regenerative medicine (ROKIT Healthcare), rare disease (Orum Therapeutics)
• Consumer tech and commerce: grocery delivery (Kurly), fashion (Musinsa), travel (My Real Trip), digital content (RIDI)
• AI and enterprise software: mobile ad platforms (Moloco), AI advertising, enterprise SaaS
• Media and entertainment: e-books (RIDI), gaming (Kong Studios), virtual idol content (Blast/Plave)

The firm has invested in 297 companies over 14 years with exposure across Life Sciences (32 investments), High Tech (31), Enterprise Applications (24), HealthTech (16), and Consumer (14), plus 125 more across other sectors.

Stage Focus

DSC primarily targets Seed and Series A, though it invests across all stages:

• Seed (28 first investments, avg round size $4.08M)
• Series A (45 first investments, avg round size $11.2M) — primary stage
• Series B (27 first investments, avg round size $25.2M)
• Follow-on investments in existing portfolio companies at later stages

The firm has also expanded into venture secondaries via its Schmidt subsidiary and a dedicated secondary fund.

Check Size

Typical first-round check size ranges from $1M to $30M, depending on stage:

• Seed: approximately $1M–$5M
• Series A: approximately $5M–$20M
• Series B: approximately $10M–$30M

The firm manages 23 funds with approximately $933 million in total AUM.

Lead Tendency

DSC both leads and participates in rounds. At the founding and seed stage, DSC often leads as the first institutional investor. At later stages it frequently co-invests alongside other top Korean VCs such as Korea Investment Holdings, Atinum Investment, LB Investment, and AJU IB Investment.

Recent Activity and Fund Status

DSC is actively deploying from its current funds:

• 2026 (YTD, as of April 2026): 5 investments
  • CarbonSix (Physical AI, US, Series A)
  • XCENA (South Korea, Series B)
  • Clobe (South Korea, Seed)
  • Aiark (US AI, Series A)
  • Breezebio (US biotech, Series B)
• 2025: 11 total investments (8 new, 3 follow-on)
• 2024: 13 total investments (9 new, 4 follow-on)

In May 2024, DSC formed Korea's largest-ever VC secondary fund at 300 billion KRW (~$219M), expanding its strategy beyond primary investments into VC secondaries. The firm began this secondary push in 2021.

Portfolio Highlights

DSC Investment's portfolio includes 6 unicorns, 52 IPOs, and 13 acquisitions:

Unicorns:

• Moloco (AI-powered mobile ad platform, Redwood City; Nasdaq IPO anticipated 2026; recorded 640.5B KRW revenue in 2025)
• Kurly (Market Kurly, online grocery, Seoul; Series G, $654M raised)
• Musinsa (fashion e-commerce, Seoul; Series C, $474M raised)
• RIDI (e-book platform, Seoul)
• Kong Studios (mobile game developer, San Francisco)

Deep Tech Stars:

• FuriosaAI: AI semiconductor fabless (Korea); DSC is the largest institutional investor with founding-stage entry + 5 follow-on investments. Meta attempted acquisition in 2025; company pivoted to Korean IPO instead.
• MangoBoost: DPU and AI server infrastructure (Korea/US); unicorn candidate; Series A at $55M in 2023; valued at 400B KRW.
• SemiFive: AI semiconductor design; KOSDAQ IPO December 2025 ($564M market cap at listing).

Notable Exits:

• Bear Robotics (acquired January 2025)
• Harmonic Bionics (acquired June 2025)
• Dunamu (crypto exchange operator, November 2025)
• Phantom (acquired by Harbinger Motors, February 2026)

Biotech:

• Pinetree Therapeutics: EGFR degrader licensed to AstraZeneca for $500M deal (2024)
• ABL Bio: bispecific antibody platform (KOSDAQ listed)
• ROKIT Healthcare: personalized organ regeneration (KOSDAQ IPO May 2025)

Content:

• Blast: creator of virtual idol 'Plave'; backed by HYBE and YG; Asia tour sold out in 2025
• My Real Trip: Korean travel platform (Series F, $98.9M raised)
• Kakao: internet/messaging conglomerate (public)

Team

• Yoon Geon-su, CEO & Founder: Started career at LG Institute of Technology (1988), entered venture investment at Korea Technology Investment (1999), joined LB Investment (2007), and founded DSC Investment in 2012. Chairman of Korea Venture Capital Association (2024).
• Yo-han Kim, Partner
• Jeong-un Park, Partner
• Minji Kimm, Partner
• Ara Go, Partner
• Han-byeol Lee, Partner
• Dongwon Shin, Partner
• Seongmin Kang, Partner
• Jongmin Kwon, Partner
• Hyunjun Kim, Partner

The firm has 29 total staff and 11 partners. DSC also runs Schmidt, an accelerator subsidiary focused on seed-to-bridge deep tech investments, and Ddokddok, which built a VC ERP system for portfolio management. The firm dedicates full-time staff to exit strategy design and execution.

Decision Process

DSC Investment operates as a partnership with an investment committee. The firm has historically led deals at early stages and co-invested with other top Korean VCs at growth stages. Dedicated post-investment teams handle value creation and exit strategy.

Geographic Focus

Primarily South Korea (92 first investments), with meaningful international activity:

• United States (17 investments, especially deep tech and biotech)
• Israel (3)
• Singapore (2)
• China (1)

Founder Preferences

DSC favors early-stage technical founders building in deep tech, biotech, AI, and consumer internet. The firm's Schmidt accelerator specifically scouts founding-stage deep tech entrepreneurs. DSC has backed founders from academia (e.g., MangoBoost's SNU professor) and serial entrepreneurs in consumer and content sectors.

Key Co-Investors

Korea Investment Holdings (11 deals), Atinum Investment, Korean Development Bank, LB Investment, AJU IB Investment, SV Investment, and KTB Network.